Gamma West

Gamma West operates as a network of clinics providing specialized radiation oncology services. Founded in 1998, the company has established a significant presence in the mountain west region of the United States, including Utah, Nevada, Wyoming, and Idaho. The firm was co-founded by CEO Dave Vincent and Dr. John K. Hayes, who also serves as the President and Medical Director. Their business model centers on partnering with hospitals to deliver advanced cancer care within local communities. In May 2019, Gamma West was acquired by Integrated Oncology Network (ION), a physician and radiation oncology management company, to further expand its services and growth.

The company's core business is the provision of sophisticated cancer treatments, with a focus on patients with breast, prostate, and various other types of cancer. Gamma West offers precise, less invasive radiation therapies designed to minimize damage to healthy surrounding tissue, which can lead to fewer side effects and shorter treatment times. Their main services include TomoTherapy and Brachytherapy. TomoTherapy combines the precision of CT scanning technology with intensity-modulated radiation therapy (IMRT), delivering targeted radiation beams from all angles. This method is particularly effective for hard-to-reach tumors or those near vital organs. Brachytherapy, also known as internal radiation, involves placing a radioactive source directly inside or next to a tumor, allowing for a high dose of radiation to be delivered to a localized area. It can be administered as a permanent, low-dose-rate (LDR) seed implant or as a temporary, high-dose-rate (HDR) treatment.

Gamma West's revenue is generated by providing these clinical oncology services to patients. The company operates through multiple medical group practices and clinics, often located within or in partnership with larger hospital systems like Davis Hospital and Medical Center and St. Mark's Hospital. This partnership model allows them to leverage hospital infrastructure while providing their specialized expertise and technology. The acquisition by ION indicates a strategy focused on affiliating with quality healthcare systems to broaden their value proposition and continue their growth across the United States.

Keywords: radiation oncology, cancer treatment, Brachytherapy, TomoTherapy, oncology clinics, cancer care, radiation therapy, Integrated Oncology Network, prostate cancer therapy, breast cancer therapy, outpatient oncology, IMRT, image-guided radiation therapy, internal radiation therapy, high-dose rate radiation, low-dose rate radiation, stereotactic radiosurgery, cancer services, Utah healthcare, medical oncology